Healios K.K. (OTCMKTS:HLOSF – Get Free Report)’s share price shot up 3.1% during mid-day trading on Tuesday . The stock traded as high as $2.00 and last traded at $2.00. 2,621 shares traded hands during mid-day trading, an increase of 15% from the average session volume of 2,275 shares. The stock had previously closed at $1.94.
Healios K.K. Stock Up 3.1 %
The business’s fifty day moving average is $1.83 and its 200-day moving average is $1.47.
About Healios K.K.
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
Read More
- Five stocks we like better than Healios K.K.
- What Investors Need to Know About Upcoming IPOs
- How to Invest in Micro-Cap Stocks Like a Pro
- Airline Stocks – Top Airline Stocks to Buy Now
- Investors Sell Microsoft Stock on OpenAI News—Time to Buy?
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Take-Two Interactive: A Defensive Play Set to Explode
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20230314142016&h=45&w=95&zc=2){kind=logo}